Association of iron supplementation, HFE and AMPD1 polymorphisms and biochemical iron metabolism parameters in the performance of a men’s World Tour cycling team: A pilot study

ElsevierVolume 84, July 2024, 127470Journal of Trace Elements in Medicine and BiologyAuthor links open overlay panelHighlights•

Iron supplementation could be related to performance in a in a World Tour cycling team.

Biochemical iron metabolism parameters are influenced by genetic polymorphisms in HFE and AMPD1 under iron supplementation.

The increasing hemoglobin and hematocrit concentration was associated with winning in cyclists with GC genotype in HFE gene.

AMPD1 gene has an effect in serum iron to compete in three-week Grand Tours and winning in professional cyclists.

AbstractBackground

Nutritional strategies with iron supplementation have been shown to be effective in preventing the decline of blood biochemical parameters and sports performance. The aim of the study was to describe biochemical iron metabolism parameters in association with iron supplementation and HFE and AMPD1 polymorphisms in a Union Cycliste Internationale (UCI) World Tour cycling team to evaluate performance during a whole season

Methods

Twenty-eight professional men cyclists took part in this longitudinal observational pilot study. AMPD1 c.34 C>T (rs17602729) and HFE c.187 C>G (rs1799945) polymorphisms were genotyped using Single Nucleotide Primer Extension (SNPE). All the professional cyclists took oral iron supplementation throughout the season. Four complete blood analyses were carried out corresponding to UCI controls in January (1st), April (2nd), June (3rd) and October (4th). Data on participation in three-week Grand Tours, kms of competition and wins were analyzed. Results: In performance, especially in wins, there was a significant effect in HFE on biochemical hemoglobin (F = 4.255; p = 0.021) and biochemical hematocrit (F = 5.335; p = 0.009) and a hematocrit biochemical × genotype interaction (F = 3.418; p = 0.041), with higher values in professional cyclist with GC genotype. In AMPD1 there were significant effects in the biochemical iron x genotype interaction in three-week Grand Tours (F = 3.874; p = 0.029) and wins (F = 3.930; p = 0.028)

Conclusions

Blood biochemical iron metabolism parameters could be related to performance in the season due to increasing hemoglobin and hematocrit concentration under iron supplementation, associated with winning in the professional cyclists with GC genotype of the HFE polymorphism.

Keywords

Elite cyclist

Iron supplementation

Genetics

Performance

Hemoglobin

Hematocrit

© 2024 The Author(s). Published by Elsevier GmbH.

留言 (0)

沒有登入
gif